Search results
Scarlett Johansson & Channing Tatum Reveal Fly Me to the Moon Final Trailer
Comic Book· 23 hours agoScarlett Johansson and Channing Tatum gave an introduction for thier new movie Fly Me to the Moon....
Perspective Therapeutics (NYSE:CATX) Rating Reiterated by Oppenheimer
ETF DAILY NEWS· 1 day agoPerspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “outperform” rating restated...
Is OOSAX a Strong Bond Fund Right Now?
Zacks via Yahoo Finance· 2 days agoIf investors are looking at the Diversified Bonds fund category, make sure to pass over Oppenheimer Senior Floating Rate A (OOSAX). OOSAX bears a Zacks...
How Vannevar Bush Engineered the 20th Century
IEEE Spectrum· 3 days agoIn the summer of 1945, Robert J. Oppenheimer and other key members of the Manhattan Project gathered in New Mexico to witness the first atomic bomb test....
Thomasville National Bank Raises Stock Holdings in TC Bancshares, Inc. (NASDAQ:TCBC)
ETF DAILY NEWS· 5 hours agoThomasville National Bank grew its stake in TC Bancshares, Inc. (NASDAQ:TCBC – Free Report) by 7.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities & ...
11 Biopics You Should Watch With Your Kids
Lifehacker· 24 hours agoFrom Walk the Line to Oppenheimer, biopics can introduce audiences to inspirational and complicated individuals who achieved greatness through innovative thinking or sheer ...
Spirit Aero downgraded, Skyworks upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 1 day agoPrelude's upcoming catalysts are "intriguing," but the firm currently finds them "hard to derisk"...
Oppenheimer Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $25.00
ETF DAILY NEWS· 2 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective trimmed by Oppenheimer from $50.00 to $25.00 in a report issued on Tuesday morning, Benzinga reports ...
Citi hikes target price on Microsoft stock to $520: Can it reach there? | Invezz
Invezz· 1 hour agoOn Friday, analysts at Citi increased their target price on Microsoft Corp (NASDAQ:MSFT) from $495...
Oppenheimer Lowers Ovid Therapeutics (NASDAQ:OVID) to Market Perform
ETF DAILY NEWS· 3 days agoOvid Therapeutics (NASDAQ:OVID – Get Free Report) was downgraded by stock analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a report issued ...
